Acadia Healthcare (NASDAQ:ACHC) Given New $29.00 Price Target at Guggenheim

Key Points

• Guggenheim has lowered its price target for Acadia Healthcare from $36.00 to $29.00, maintaining a "buy" rating, which suggests a potential upside of 60.11% from its current price.
• Multiple analysts have adjusted their price targets, with Barclays and KeyCorp making significant cuts, leading to an average target price of $46.28 and a consensus rating of "Moderate Buy".
• Acadia Healthcare's recent earnings report showed a quarterly revenue of $869.23 million, exceeding analyst expectations, and reported an earnings per share (EPS) of $0.83, surpassing the consensus estimate.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) had its price target dropped by equities researchers at Guggenheim from $36.00 to $29.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a "buy" rating on the stock. Guggenheim's price target would indicate a potential upside of 60.11% from the stock's current price.

Several other analysts have also issued reports on the company. Barclays cut their target price on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research note on Thursday. KeyCorp cut their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Mizuho lowered their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. Finally, Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $46.28.

Acadia Healthcare Stock Up 0.6%

ACHC traded up $0.11 during midday trading on Thursday, hitting $18.11. The company had a trading volume of 445,861 shares, compared to its average volume of 2,164,348. The stock's 50 day moving average price is $22.34 and its 200 day moving average price is $28.23. Acadia Healthcare has a 52 week low of $17.13 and a 52 week high of $82.40. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $1.67 billion, a price-to-earnings ratio of 12.03, a PEG ratio of 4.15 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.36%. The company had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. During the same quarter last year, the business posted $0.91 EPS. Acadia Healthcare's quarterly revenue was up 9.2% compared to the same quarter last year. On average, research analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Several hedge funds have recently bought and sold shares of the company. UMB Bank n.a. raised its stake in Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after buying an additional 755 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after purchasing an additional 1,234 shares during the last quarter. Quadrant Capital Group LLC increased its position in Acadia Healthcare by 287.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock worth $50,000 after buying an additional 933 shares during the period. State of Wyoming purchased a new position in shares of Acadia Healthcare during the fourth quarter worth approximately $56,000. Finally, Covestor Ltd raised its position in Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after purchasing an additional 310 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.